Compare Nuwellis Inc (NUWE) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Invesco Preferred ETF — how do they compare? Nuwellis Inc trades at $0.79 (market cap $2.54M), while Invesco Preferred ETF trades at $10.38. Which is the better fit depends on your goals.
| NUWE | PGX | |
|---|---|---|
Market Cap | $2.54M | — |
Sector | Technology | — |
52-Week High | $164.50 | $11.87 |
52-Week Low | $0.73 | $10.46 |
Enterprise Value | -$1.17M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
PGX trades at $10.49 with no recent price movement, showing technical bearish signals from moving averages but bullish momentum from oscillators. The stock faces resistance at $11 with support at $10. Recent corporate actions include scheduled dividends for mid-2026. Financial ratios remain unavailable, limiting fundamental assessment.
The outlook is mixed with technical indicators conflicting between bearish trend and oversold bounce potential. Key risks include limited financial transparency and market sentiment challenges. Investment opportunity hinges on future financial disclosures and dividend execution stability amid current technical uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
